Bharat Biotech completes trials for India’s first intranasal Covid vaccine, says it’s safe, immunoge-
By Express News Service HYDERABAD: City-based Bharat Biotech on Monday announced it had completed clinical development for phase III trials […]
By Express News Service HYDERABAD: City-based Bharat Biotech on Monday announced it had completed clinical development for phase III trials […]
By Online Desk Bharat Biotech International Limited (BBIL) on Friday announced that its COVID-19 vaccine Covaxin has proven to be
By PTI NEW DELHI: Prime Minister Narendra Modi will inaugurate the Biotech Startup Expo – 2022 here on June 9,
Express News Service NEW DELHI: The World Health Organisation (WHO) has said it has suspended the supply through United Nations
By PTI NEW DELHI/ HYDERABAD: India’s drug regulator has given permission to Bharat Biotech to conduct phase-3 clinical trial for
By PTI NEW DELHI: Bharat Biotech has sought from the Drugs Controller General of India regular market approval for its
Express News Service NEW DELHI: Covaxin maker Bharat Biotech on Wednesday claimed that the booster shot of the Covid vaccine
Express News Service NEW DELHI: A third booster dose of Covaxin, the Covid19 vaccine by Bharat Biotech, is safe and
Express News Service NEW DELHI: Days after the government announced that 15 to 17-year-olds in India will be eligible for
By PTI HYDERABAD: Bharat Biotech has sought the Drug Controller General of India’s approval to conduct phase-3 trials of its